Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength.
By L. Schaap, S. Pluijm, D. Deeg, Tamara B. Harris, Stephen B. Kritchevsky, Anne B. Newman, L. Colbert, Marco Pahor, S. Rubin, Fran Tylavsky and 1 more. The journals of gerontology. Series A, Biological sciences and medical sciences, 2009
665 citations recorded by the source corpus.
Subfields: Epidemiology, Molecular Biology, Physiology
View Paper: https://www.semanticscholar.org/paper/edfcdfa9e56ecd10878ef9f388535eda7f0e86bc
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Andrea Bernetti
- Odessa Addison
- M. Paoloni
- A. Ryan
- Paul LaStayo
- M. Mangone
- V. Santilli
- R. Marcus
Citations in the corpus
- Clinical definition of sarcopenia. (2014, background): “(28, 29) reported that TNF-a and its soluble receptors showed the most consistent associations with decline in muscle mass and strength.”
- Intermuscular Fat: A Review of the Consequences and Causes (2014, background): “Interestingly, several authors have reported relationships between increased proinflammatory cytokines and decreased muscle [83, 84] and mobility function [85–87] that are strikingly similar to those reported between IMAT and muscle and mobility function [19].”